Determination of pravastatin in human plasma by high-performance liquid chromatography with ultraviolet detection
- 1 April 1998
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 708 (1-2) , 235-241
- https://doi.org/10.1016/s0378-4347(97)00625-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics and oral bioavailability of pravastatin in dogsInternational Journal of Pharmaceutics, 1996
- Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and LovastatinThe Journal of Clinical Pharmacology, 1990
- Disposition of pravastatin sodium, a tissue‐selective HMG‐CoA reductase inhibitor, in healthy subjects.British Journal of Clinical Pharmacology, 1990
- Determination of pravastatin sodium and its isomeric metabolite in human urine by HPLC with UV detectionJournal of Pharmaceutical and Biomedical Analysis, 1989
- The Effect of CS-514 on Serum Lipids and Apolipoproteins in Hypercholesterolemic SubjectsJAMA, 1987
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981